A recombinant form of this human IgM was tested in two distinct models of neurological disease with very different mechanisms of cell death: (1) a model of axonal injury mediated by a persistent picornovirus and immune attack and, (2) models of ALS driven by a mutation of a protein that is normally involved in preventing oxidative stress. This evidence concerns the gene CD40LG and nervous system disorder.